Jan 2, 2024 Central Drugs Standard Control Organization, Government of India has announced that w.e.f 01.01.2024 online applications for some of the registration/ licensure activities shall now be made through NSWS portal i.e. www.nsws.gov.in. Accordingly, all stakeholders shall henceforth apply…
Dec 22, 2023 US Food and Drugs Administration (USFDA) has approved TARPEYO (budesonide) delayed release capsules to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression. TARPEYO was first approved…
December 14, 2023 The European Commission (EC), the Heads of Medicines Agencies (HMA) and EMA have published the first version of the Union list of critical medicines. It contains more than 200 active substances of medicines for human use considered…
December 13, 2023 WS Global, INC Brooklyn, NY has initiated voluntarily recall of all lots of Himalayan Pain Relief Tea, tea packets to the consumer level. The products have been found to contain undeclared drugs viz. Diclofenac and Dexamethasone.…
18 June, 2022 Central Drugs Standard Control Organization (CDSCO), the central drug regulatory agency of Government of India has published the list of all the vaccines approved in India for the prophylaxis of Covid-19. The data consists of all…
Recent Post
- CDSCO Issues Public Notice on Disposal of Long-Pending SUGAM Applications
- India Bans High-Dose Nimesulide: What You Need to Know
- Compounding of Offences under the Drugs and Cosmetics Act, 1940: What Stakeholders Need to Know
- 🚨 CDSCO Directive on Immediate Inspections as per Revised Schedule M – Is Your Facility Ready?
- CDSCO Issues Regulatory Clarification on Combi-Pack Approvals: Key Insights for Injectable Manufacturers
